drugset / Trial / NCT05111002
Lefamulin for M. Genitalium Treatment Failures
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this drug study is to find out whether the antibiotic lefamulin (trade name Xenleta) will cure Mycoplasma genitalium infections that have not been cured by prior antibiotics while finding out whether it is more effective if the antibiotic doxycycline is taken first.
Timeline
- Start
- 2022-04-22
- Primary completion
- 2023-11-30
- Completion
- 2023-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxycycline | Small molecule | 100 mg | Oral |
| Subject | Lefamulin | Other / unclassified | 600 mg | Oral |